Although uncertainty in M&A markets persists due to the escalating US-China trade war, a sense of optimism prevails. While one door closes on the other side of the Pacific, China opens its own door wider to overseas trade by announcing policy changes designed to welcome inbound and outbound investment and lifting restrictions on foreign capital in 22 formerly prohibited sectors.
We turn the spotlight on the fast-growing sector of medical devices via a case study of China Grand Pharmaceutical’s acquisition of Sirtex Medical, whose products represent a revolutionary way to treat liver cancer.
John Zhang, our local Oaklins specialist, examines the potential for hot commodities in a cold-war climate.
© 2019 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.